science wire



Results 1 - 50 of 2172.
1 2 3 4 5 ... 44 Next »

Pharmacology - Social Sciences - 21.01.2021
Randomised trials could help to return children safely to schools - study
Randomised trials could help to return children safely to schools - study
Schools are closing again in response to surging levels of COVID-19 infection, but staging randomised trials when students eventually return could help to clarify uncertainties around when we should send children back to the classroom, according to a new study.

Health - Pharmacology - 20.01.2021
Designer DNA Therapeutic Wipes Out Cancer Stem Cells, Treats Multiple Myeloma in Mice
Study supports launch of Phase I clinical trial to test a designer DNA agent - an antisense oligonucleotide that targets a gene called IRF4 - in patients with multiple myeloma Many patients with multiple myeloma, a type of blood cancer, eventually develop resistance to one treatment after another.

Health - Pharmacology - 18.01.2021
RECOVERY trial closes recruitment to convalescent plasma treatment for patients hospitalised with COVID-19 | University of Oxford
The RECOVERY trial was established as a randomised clinical trial to test a range of potential treatments for COVID-19.

Health - Pharmacology - 18.01.2021
Birmingham maternity experts call for urgent action on pregnancy 'drug drought'
Birmingham maternity experts call for urgent action on pregnancy ’drug drought’
Leaders in maternal healthcare have called for lifesaving research into pharmaceuticals for use during pregnancy in a new report highlighting the challenges of pregnancy-related complications, pre-term birth and pre-existing conditions.

Pharmacology - Health - 14.01.2021
Novartis ligelizumab (QGE031) receives FDA Breakthrough Therapy designation for patients with chronic spontaneous urticaria (CSU)
Ligelizumab is the first treatment to receive FDA Breakthrough Therapy designation in chronic spontaneous urticaria (CSU) in patients with an inadequate response to H1-antihistamines 1   Currently th

Pharmacology - Health - 12.01.2021
Second COVID-19 vaccine approved for Switzerland
On 12 January 2021 Swissmedic, the Swiss agency for the authorisation and supervision of therapeutic products, approved the second COVID-19 vaccination for the Swiss market.

Health - Pharmacology - 08.01.2021
Welsh ’wellness’ tea arrives in lockdown
The first batch of a new wellness green tea blended with pure Welsh honey and scientifically identified botanicals has arrived in Wales.

Health - Pharmacology - 06.01.2021
Global experts urge everyone to talk about COVID-19 vaccines responsibly
Global experts urge everyone to talk about COVID-19 vaccines responsibly
A team of renowned scientific experts has joined forces from across the world to help fight the spread of misinformation about the COVID-19 vaccines, which hold the key to beating the deadly pandemic and releasing countries from debilitating lockdown restrictions.

Health - Pharmacology - 06.01.2021
LifeArc funds COVID-19 drug screening hub at the University of Glasgow
A new COVID-19 drug screening and resistance hub will be established in Scotland, based at the MRC-University of Glasgow Centre for Virus Research (CVR).

Health - Pharmacology - 05.01.2021
New Ebolavirus treatment sees the light thanks to basic research performed in Ticino
While populations around the world are being vaccinated against SARS-CoV-2, the U.S. Food and Drug Administration has announced the approval of a treament against another well-known virus, much less widespread but extremely lethal: Ebola.

Pharmacology - Health - 19.12.2020
Swissmedic grants authorisation for the first COVID-19 vaccine in Switzerland
Vaccine from Pfizer/BioNTech authorised in the rolling review procedure after close scrutiny of the risks and benefits Swissmedic has authorised the vaccine from Pfizer/BioNTech.

Life Sciences - Pharmacology - 18.12.2020
A weather station for epileptic seizure
A weather station for epileptic seizure
The unpredictability of epileptic seizures is a severe handicap for patients.

Health - Pharmacology - 18.12.2020
U-M publishes free guides packed with advice and wisdom from COVID-19 patients, caregivers
Practical tips for COVID-19 hospital and post-hospital care available for anyone to use, and for any hospital or health system to adapt and publish No one likes to venture into a new city or country without a map or guidebook.

Pharmacology - Health - 17.12.2020
Opinion: Coronavirus vaccines - how will we know when life can go back to normal?
The first people have begun to receive vaccines as part of mass vaccination campaigns to immunise people against Covid-19. Excitement is building - finally, the end of the coronavirus crisis is in sight, writes Dr Jasmina Panovska-Griffiths (UCL Epidemiology & Health). Since early December, elderly patients and health workers in 50 hospitals across the UK have been given the vaccine developed by Pfizer and BioNTech.

Health - Pharmacology - 17.12.2020

Health - Pharmacology - 16.12.2020
AI could help cut waiting times for cancer by automating mark-up of patient scans prior to radiotherapy
Doctors at Addenbrooke's Hospital in Cambridge aim to drastically cut cancer waiting times by using artificial intelligence (AI) to automate lengthy radiotherapy preparations.

Pharmacology - Health - 16.12.2020
Novartis investigational oral therapy iptacopan (LNP023) receives FDA Breakthrough Therapy Designation for PNH and Rare Pediatric Disease Designation for C3G
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare and life-threatening blood disorder, resulting in debilitating symptoms that can impact patients' quality of life 1-3 C3 glomerulopathy (C3G) is a

Health - Pharmacology - 16.12.2020
Researchers call for people with mental illness to have top priority for COVID-19 vaccine
People with serious mental illness should be given priority access to a COVID-19 vaccine when one becomes available, say University of Queensland researchers. Studies show people with serious mental illness are more likely to be infected by the COVID-19 virus and have higher rates of hospitalisation due to medications, poorer general health, reduced access to medical care, lower socio-economic status, overcrowding, smoking and obesity.

Health - Pharmacology - 16.12.2020
New Scottish study to "REACH" people with heart failure at home
REACH-HF - is an award winning cardiac rehabilitation programme which helps people living with heart failure improve their quality of life from the comfort and safety of their own homes - is being rolled out in six NHS Scotland Health Boards from this month.

Pharmacology - Health - 16.12.2020
Novartis announces positive FDA Advisory Committee recommendation for use of Entresto to treat patients with HFpEF
The Committee voted 12 to 1 that the data presented support the use of Entresto in treatment of patients with heart failure with preserved ejection fraction (HFpEF) Potential Q1 2021 sNDA approval co

Health - Pharmacology - 15.12.2020
Vaccines must prevent infection, disease progression and transmission - in every country - to truly bring COVID-19 under control
An editorial co-authored by a member of the UK's influential SAGE committee that advises the UK Government on COVID-19, and published in Anaesthesia (a journal of the Association of Anaesthetists) sa

Health - Pharmacology - 15.12.2020
New synthetic molecule can kill the flu virus
New synthetic molecule can kill the flu virus
Scientists have developed a synthetic molecule capable of killing the virus that causes influenza. They hope their discovery will lead to an effective drug treatment.

Pharmacology - Health - 15.12.2020
Novartis reports positive topline results from second Phase III trial of Beovu in patients with diabetic macular edema
In Phase III KESTREL study, Beovu (brolucizumab 6 mg) achieved its primary endpoint of non-inferiority to aflibercept 2 mg in change in best-corrected visual acuity (BCVA) at year one (week 52) 1 In

Pharmacology - Health - 14.12.2020

Health - Pharmacology - 11.12.2020
No deal Brexit could have detrimental impact for four million people in UK living with a rare disease
No deal Brexit could have detrimental impact for four million people in UK living with a rare disease
Experts have warned that a 'no deal' Brexit will result in the exclusion of the UK from the 24 European Reference Networks (ERNs) that were established to improve the care of patients bearing the lifelong burden of a rare disease, which require highly specialised diagnosis and treatment.

Health - Pharmacology - 11.12.2020
Update on UQ COVID-19 vaccine
The University of Queensland and CSL today announce that the Phase 1 trial of the UQ-CSL v451 COVID-19 vaccine has shown that it elicits a robust response towards the virus and has a strong safety profile.

Health - Pharmacology - 11.12.2020
Roche launches laboratory SARS-CoV-2 antigen test to support high-volume testing of suspected COVID-19 patients
The Elecsys SARS-CoV-2 Antigen test is an automated laboratory assay intended as an aid in the diagnosis of active SARS-CoV-2 infection Roche will be able to ramp up to a double-digit million number

Health - Pharmacology - 10.12.2020
New Personalized Immunotherapy Trial Launched Despite COVID-19 Pandemic
First patient to receive individualized TIL therapy undergoes treatment at Moores Cancer Center Since 2016, Bernard Thurman has undergone traditional treatments, experimental therapies and surgeries to counter the cancer within him, but nothing successfully eradicated the disease.

Health - Pharmacology - 09.12.2020
Novartis Kisqali demonstrates nearly five years median overall survival in metastatic breast cancer
  MONALEESA-7 median overall survival (OS) results reinforce Kisqali as the CDK4/6 inhibitor with un rivaled OS evidence 1 Kisqali plus endocrine therapy had a median OS of nearly five years (58&peri

Health - Pharmacology - 09.12.2020
Roche partners with Moderna to include SARS-CoV-2 antibody test in ongoing COVID-19 vaccine trials
Moderna's vaccine triggers an antibody response to the SARS-CoV-2 spike protein The Elecsys Anti-SARS-CoV-2 S test can quantitatively measure the level of antibodies against SARS-CoV-2 in vaccine tri
1 2 3 4 5 ... 44 Next »

This site uses cookies and analysis tools to improve the usability of the site. More information. |